人間拡張市場：タイプ別、機能別、最終用途別-2025-2030年の世界予測

人間拡張市場の2023年の市場規模は2,558億4,000万米ドルで、2024年には2,962億4,000万米ドルに達すると予測され、CAGR 15.96％で成長し、2030年には7,214億4,000万米ドルに達すると予測されています。

人間拡張とは、身体的または認知的に人間の能力やパフォーマンスを向上させるために使用される技術やテクニックのことです。ウェアラブル・ガジェット、外骨格、ブレイン・マシン・インターフェイス、遺伝子強化など、幅広い用途が含まれます。この分野は、特に障害、ヘルスケア、労働生産性の分野において、人間の効率、健康、生活の質を向上させる必要性によって推進されています。ヘルスケアと軍事分野は、身体的パフォーマンスと意思決定能力の向上がもたらす潜在的なメリットにより、重要な最終用途範囲となっています。人間拡張市場は、AI、IoT、ナノテクノロジーなどの技術の進歩に影響され、個別化医療、学習環境の強化、精密なヒューマン・マシン・インターフェースを必要とする産業における機会を生み出しています。ハイテク大手からの投資の増加や、高齢者介護における支援機器の需要の増加が、市場をさらに後押ししています。しかし、この分野は、倫理的な懸念、開発と実装の高コスト、技術革新を遅らせる可能性のある厳しい規制枠組みなどの課題に直面しています。主な限界としては、技術の悪用の可能性や、特にブレイン・マシン・インターフェイスに関するプライバシーの問題が挙げられます。より手頃な価格のウェアラブル・デバイスの開発や、ユーザー・インターフェース・システムの改善がイノベーションをもたらす可能性があります。人間の入力をより自然かつ効率的に解釈するAIの能力強化に関する研究は活況を呈しています。企業は医療機関との共同プロジェクトに注力することで、医療ニーズや患者の受け入れ態勢と技術の進歩をより合致させることができると思われます。さらに、認知機能強化ツールによってクリエイティブ産業や労働者の生産性を向上させる人間拡張を探求する可能性もあります。市場は主にイノベーション主導型であり、新興技術、倫理指針、消費者受容動向への絶え間ない適応を必要とするダイナミックな状況です。倫理的な開発、費用対効果、ユーザー中心のデザインに焦点を当てることで、企業はリスクを軽減しながら人間拡張の可能性を最大限に活用することができます。

市場力学：急速に進化する人間拡張市場の主要市場インサイトを公開

人間拡張市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 認知および身体強化アプリケーションに対する認識と受容の高まり
  • 医療用ウェアラブルデバイスに対する人間拡張ニーズの高まり
  • ジェスチャートラッキングを目的とした航空宇宙・防衛分野からの需要の増加
• 市場抑制要因
  • 人間拡張技術の開発コストの高さ
• 市場機会
  • 技術的に高度な人間拡張の継続的なイントロダクション
  • 人間拡張技術発展のための政府支援と民間投資
• 市場の課題
  • 人間拡張技術の使用によるデータ漏洩と個人情報漏洩のリスク

ポーターの5つの力：人間拡張市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、人間拡張市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：人間拡張市場における外部からの影響の把握

外部マクロ環境要因は、人間拡張市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析人間拡張市場における競合情勢の把握

人間拡張市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス人間拡張市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人間拡張市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 認知能力と身体能力を高めるアプリケーションに対する認識と受容の高まり
    • 医療用ウェアラブルデバイスに対する人間拡張の需要の高まり
    • 航空宇宙および防衛分野におけるジェスチャートラッキングの需要増加
  • 抑制要因
    • 人間拡張技術の開発コストが高い
  • 機会
    • 技術的に高度な人間拡張の継続的なイントロダクション
    • 技術の発展に向けた政府の支援と民間投資
  • 課題
    • 人間拡張テクノロジーの使用によるデータおよび個人情報漏洩のリスク
• 市場セグメンテーション分析
  • タイプ：ハンズフリーのデータアクセスとナビゲーションガイダンスを提供するための拡張現実デバイスの使用拡大
  • 機能性：身体に装着する人間拡張の使用を増やし、機動性と持久力を高める
  • エンドユーザー：製造業における人間拡張テクノロジーの適用を拡大し、労働者の生産性と効率性を向上させる
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 人間拡張市場：タイプ別

• 拡張現実デバイス
• 生体認証システム
• 外骨格
• インテリジェントな仮想アシスタント
• バーチャルリアリティデバイス
• ウェアラブルデバイス

第7章 人間拡張市場機能別

• ボディウェア
• 非身体装着型

第8章 人間拡張市場：最終用途別

• 航空宇宙および防衛
• ヘルスケア
• 製造業
• メディアとエンターテイメント

第9章 南北アメリカの人間拡張市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の人間拡張市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの人間拡張市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • GoogleとQualcommが提携しウェアラブルデバイス向けRISC-Vチップを開発
  • Vuzix、Quanta Computerと提携契約を締結
  • Humane、OpenAI搭載ウェアラブル「AI Pin」を正式に発売
  • 人間のつながりを実現する：Phantom Neuroが人間拡張とIoTを融合
  • SFUの研究者が開発したXoMotionは、移動が困難な人のための世界で最も先進的な外骨格となる
  • デュポン、STマイクロエレクトロニクス（ST）と提携し、生体信号をモニタリングする新しいスマートウェアラブルデバイスのコンセプトを開発
  • ウェアラブル企業OuraがデジタルIDスタートアップProxyを買収
  • 防衛における人間の能力を高めるための斬新な人間拡張イノベーションに200万ユーロの資金提供
  • ARIA調査、シドニーに人間拡張研究所を建設するために140万米ドルの助成金を獲得
  • Ekso Bionics、パーカー・ハネフィン社からIndego製品ラインを含むヒューマンモーション＆コントロール事業部門の買収を発表
  • 京セラ、人間の能力を高める先進的なAIを搭載した新人間拡張技術プロトタイプを日本で発表
  • Dasaが新たなイノベーション重点分野を開始：人間拡張（HA）
  • パリのスタートアップ企業が人間用外骨格の開発に4,500万米ドルを調達

企業一覧

• 3M Company
• Amazon.com, Inc.
• Apple Inc.
• AppliedVR, Inc.
• Aptima, Inc.
• Atheer, Inc.
• B-Temia Inc.
• Charles River Analytics, Inc.
• Cionic, Inc.
• Cognitive Mill by AIHunters
• Continental AG
• CYBERDYNE Inc.
• Ekso Bionics Holdings, Inc.
• Esper Bionics Inc.
• Fujitsu Limited
• Garmin Limited
• General Motors Company
• Google LLC by Alphabet, Inc.
• HID Global Corporation by Assa Abloy AB
• Hocoma AG by DIH International Limited
• HTC Corporation
• Hyundai Motor Company
• IDEMIA Group, S.A.S.
• Kyocera Corporation
• Lifesense Group
• Magic Leap Inc.
• Meta Platforms, Inc.
• Microsoft Corporation
• NEC Corporation
• Nvidia Corporation
• Ottobock SE & Co. KGaA
• Panasonic Corporation
• Parker Hannifin Corporation
• Rewalk Robotics Inc.
• Rex Bionics Ltd
• Robert Bosch GmbH
• RTX Corporation
• Saab AB
• Samsung Electronics Co., Ltd.
• Soar Technology, Inc.
• Sony Group Corporation
• Thales Group
• Unity Software Inc.
• Vuzix Corporation

LIST OF FIGURES

• FIGURE 1. HUMAN AUGMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. HUMAN AUGMENTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HUMAN AUGMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HUMAN AUGMENTATION MARKET DYNAMICS
• TABLE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 34. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 51. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 54. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 106. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 118. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 121. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 149. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

The Human Augmentation Market was valued at USD 255.84 billion in 2023, expected to reach USD 296.24 billion in 2024, and is projected to grow at a CAGR of 15.96%, to USD 721.44 billion by 2030.

Human augmentation refers to the techniques and technologies used to enhance human capabilities and performance physically or cognitively. It encompasses a wide array of applications such as wearable gadgets, exoskeletons, brain-machine interfaces, and genetic enhancements. This field is driven by the necessity to improve human efficiency, health, and quality of life, especially in areas of disability, healthcare, and workforce productivity. Healthcare and military sectors represent significant end-use scopes due to the potential benefits of enhanced physical performance and decision-making capabilities. The market for human augmentation is influenced by advancements in technologies like AI, IoT, and nanotechnology, creating opportunities in personalized medicine, enhanced learning environments, and industries requiring precise human-machine interfaces. Growing investments from tech giants and the increasing demand for assistive devices in elder care further propel the market. However, this sector faces challenges such as ethical concerns, high costs of development and implementation, and stringent regulatory frameworks that may slow innovation. Key limitations include the potential for misuse of technology and privacy concerns, particularly with brain-machine interfaces. Innovations are likely in the development of more affordable wearable devices and improved user interface systems. Research is booming in enhancing AI capabilities to interpret human inputs more naturally and efficiently. Businesses could focus on collaborative projects with medical institutions to better align technological advancements with healthcare needs and patient acceptance. Additionally, there is potential to explore human augmentation in enhancing creative industries and workforce productivity through cognitive enhancement tools. The market is predominantly innovation-driven, with a dynamic landscape that requires constant adaptation to emerging technologies, ethical guidelines, and consumer acceptance trends. By focusing on ethical development, cost-effectiveness, and user-centric designs, businesses can harness the full potential of human augmentation while mitigating risks.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Augmentation Market

The Human Augmentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing awareness and acceptance of cognitive and physical enhancement applications
  • Rising need for human augmentation for medical wearable devices
  • Increasing demand from aerospace & defense for gesture-tracking purposes
• Market Restraints
  • High cost of development of human augmentation technologies
• Market Opportunities
  • Continuous introduction of technologically advanced human augmentation
  • Government support and private investments for advancing human augmentation technologies
• Market Challenges
  • Risk of data and identity breach with the usage of human augmentation technologies

Porter's Five Forces: A Strategic Tool for Navigating the Human Augmentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Augmentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Augmentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Augmentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Augmentation Market

A detailed market share analysis in the Human Augmentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Augmentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Augmentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Human Augmentation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amazon.com, Inc., Apple Inc., AppliedVR, Inc., Aptima, Inc., Atheer, Inc., B-Temia Inc., Charles River Analytics, Inc., Cionic, Inc., Cognitive Mill by AIHunters, Continental AG, CYBERDYNE Inc., Ekso Bionics Holdings, Inc., Esper Bionics Inc., Fujitsu Limited, Garmin Limited, General Motors Company, Google LLC by Alphabet, Inc., HID Global Corporation by Assa Abloy AB, Hocoma AG by DIH International Limited, HTC Corporation, Hyundai Motor Company, IDEMIA Group, S.A.S., Kyocera Corporation, Lifesense Group, Magic Leap Inc., Meta Platforms, Inc., Microsoft Corporation, NEC Corporation, Nvidia Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Rewalk Robotics Inc., Rex Bionics Ltd, Robert Bosch GmbH, RTX Corporation, Saab AB, Samsung Electronics Co., Ltd., Soar Technology, Inc., Sony Group Corporation, Thales Group, Unity Software Inc., and Vuzix Corporation.

Market Segmentation & Coverage

This research report categorizes the Human Augmentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Augmented Reality Device, Biometric System, Exoskeletons, Intelligent Virtual Assistants, Virtual Reality Device, and Wearable Device.
• Based on Functionality, market is studied across Body Worn and Non-Body Worn.
• Based on End-use, market is studied across Aerospace & Defense, Healthcare, Manufacturing, and Media & Entertainment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness and acceptance of cognitive and physical enhancement applications
    • 5.1.1.2. Rising need for human augmentation for medical wearable devices
    • 5.1.1.3. Increasing demand from aerospace & defense for gesture-tracking purposes
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of human augmentation technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous introduction of technologically advanced human augmentation
    • 5.1.3.2. Government support and private investments for advancing human augmentation technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of data and identity breach with the usage of human augmentation technologies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance
  • 5.2.2. Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance
  • 5.2.3. End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Human Augmentation Market, by Type

• 6.1. Introduction
• 6.2. Augmented Reality Device
• 6.3. Biometric System
• 6.4. Exoskeletons
• 6.5. Intelligent Virtual Assistants
• 6.6. Virtual Reality Device
• 6.7. Wearable Device

7. Human Augmentation Market, by Functionality

• 7.1. Introduction
• 7.2. Body Worn
• 7.3. Non-Body Worn

8. Human Augmentation Market, by End-use

• 8.1. Introduction
• 8.2. Aerospace & Defense
• 8.3. Healthcare
• 8.4. Manufacturing
• 8.5. Media & Entertainment

9. Americas Human Augmentation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Human Augmentation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Human Augmentation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Google and Qualcomm Partner to Make RISC-V Chip for Wearable Devices
  • 12.3.2. Vuzix Enters into a Partnership Agreement with Quanta Computer
  • 12.3.3. Humane Officially Launches the AI Pin, its OpenAI-powered Wearable
  • 12.3.4. Enabling Human Connectivity: Phantom Neuro Merges Human Augmentation and IoT
  • 12.3.5. XoMotion Created by SFU Researchers to be World's most Advanced Exoskeleton for Mobility Challenged
  • 12.3.6. DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals
  • 12.3.7. Wearable Company Oura Acquires Digital Identification Startup Proxy
  • 12.3.8. EUR 2 Million Funding for Novel Human Augmentation Innovations to Enhance Human Capability in Defense
  • 12.3.9. ARIA Research Receives USD 1.4 Million in Grant Funding to Build Human Augmentation Laboratory in Sydney
  • 12.3.10. Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego Product Line from Parker Hannifin Corporation
  • 12.3.11. KYOCERA Introduces New Human Augmentation Technology Prototypes in Japan with Advanced AI to Enhance Human Abilities
  • 12.3.12. Dasa Launches New Innovation Focus Area: Human Augmentation (HA)
  • 12.3.13. A Parisian Startup just Raised USD 45 Million to Build Human Exoskeletons

Companies Mentioned

• 1. 3M Company
• 2. Amazon.com, Inc.
• 3. Apple Inc.
• 4. AppliedVR, Inc.
• 5. Aptima, Inc.
• 6. Atheer, Inc.
• 7. B-Temia Inc.
• 8. Charles River Analytics, Inc.
• 9. Cionic, Inc.
• 10. Cognitive Mill by AIHunters
• 11. Continental AG
• 12. CYBERDYNE Inc.
• 13. Ekso Bionics Holdings, Inc.
• 14. Esper Bionics Inc.
• 15. Fujitsu Limited
• 16. Garmin Limited
• 17. General Motors Company
• 18. Google LLC by Alphabet, Inc.
• 19. HID Global Corporation by Assa Abloy AB
• 20. Hocoma AG by DIH International Limited
• 21. HTC Corporation
• 22. Hyundai Motor Company
• 23. IDEMIA Group, S.A.S.
• 24. Kyocera Corporation
• 25. Lifesense Group
• 26. Magic Leap Inc.
• 27. Meta Platforms, Inc.
• 28. Microsoft Corporation
• 29. NEC Corporation
• 30. Nvidia Corporation
• 31. Ottobock SE & Co. KGaA
• 32. Panasonic Corporation
• 33. Parker Hannifin Corporation
• 34. Rewalk Robotics Inc.
• 35. Rex Bionics Ltd
• 36. Robert Bosch GmbH
• 37. RTX Corporation
• 38. Saab AB
• 39. Samsung Electronics Co., Ltd.
• 40. Soar Technology, Inc.
• 41. Sony Group Corporation
• 42. Thales Group
• 43. Unity Software Inc.
• 44. Vuzix Corporation